These subtypes of breast cancer are significantly different in clinical characteristics such as associated risk factors, preferable sites of metastasis, and expression of targetable surface receptors such as estrogen receptor (ER), progesterone receptor (PR), and epidermal growth factor receptor 2 (ERBB2/HER2)6. The gene discussed is ERBB2; the disease is breast carcinoma.